Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.01M Sell
344,899
-530
-0.2% -$1.51K 0.01% 830
2025
Q4
$853K Buy
345,429
+3,170
+0.9% +$7.55K 0.01% 809
2025
Q3
$763K Buy
342,259
+2,983
+0.9% +$6.82K 0.01% 712
2025
Q2
$818K Buy
339,276
+4,759
+1% +$11.6K 0.01% 666
2025
Q1
$779K Sell
334,517
-3,157
-0.9% -$6.32K 0.01% 660
2024
Q4
$625K Sell
337,674
-8,707
-3% -$19.3K 0.01% 629
2024
Q3
$845K Sell
346,381
-13,501
-4% -$30.3K 0.02% 474
2024
Q2
$738K Buy
+359,882
New +$820K 0.01% 489
2014
Q3
Sell
-1,010
Closed -$7K 759
2014
Q2
$7K Hold
1,010
﹤0.01% 511
2014
Q1
$7K Buy
1,010
+260
+35% +$1.82K ﹤0.01% 484
2013
Q4
$6K Buy
+750
New +$5.48K ﹤0.01% 633

Other funds holding ABEV

Waverly Advisors's ABEV Position: Q1 2026 in Review

Waverly Advisors reduced its Ambev (ABEV) stake by 0.15% in Q1 2026, selling an estimated $1.51K and leaving 344,899 shares worth $1.01M. The position accounts for 0.01% of the portfolio, ranked #830.

Waverly Advisors first reported a position in ABEV in Q4 2013 and has held it in 11 quarters since. 402 funds tracked by Wall St. Rank hold ABEV as of Q1 2026.

  • Waverly Advisors held 344,899 shares of Ambev worth $1.01M as of Q1 2026.
  • Waverly Advisors sold 530 Ambev shares in Q1 2026, an estimated $1.51K.
  • Ambev made up 0.01% of Waverly Advisors's portfolio in Q1 2026, its #830 holding.
  • Waverly Advisors first reported a position in Ambev in Q4 2013 and has held it in 11 quarters since.
  • 402 funds tracked by Wall St. Rank held Ambev as of Q1 2026.

Based on Waverly Advisors's 13F filing for Q1 2026, filed 15 May 2026.